Richard G. Bach, MD

All posts by Richard G. Bach, MD

September 5th, 2013

Rosiglitazone Revisited

and

Richard G. Bach discusses his study group’s observational analysis of data from the BARI 2D trial regarding outcomes associated with rosiglitazone.